Quest Diagnostics (DGX) Change in Receivables (2009 - 2026)

Quest Diagnostics has disclosed Change in Receivables across 18 years of filings, most recently posting $79.0 million for Q2 2026.

• In Q2 2026, Change in Receivables rose 464.29% year-over-year to $79.0 million; the TTM figure through Jun 2026 stood at $250.0 million (up 242.47% YoY), while the FY2025 annual figure was $106.0 million, up 49.3% from the prior year.
• Change in Receivables came in at $79.0 million for Q2 2026 at Quest Diagnostics, down from $180.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $180.0 million in Q1 2026 to a low of -$84.0 million in Q4 2022.
• Average Change in Receivables over 5 years is $11.4 million, with a median of $6.5 million recorded in 2024.
• Year-over-year, Change in Receivables sank 133.33% in 2022 and surged 1500.0% in 2025.
• Over 5 years, Change in Receivables stood at -$84.0 million in 2022, then grew by 15.48% to -$71.0 million in 2023, then increased by 2.82% to -$69.0 million in 2024, then surged by 31.88% to -$47.0 million in 2025, then jumped by 268.09% to $79.0 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $79.0 million in Q2 2026, $180.0 million in Q1 2026, and -$47.0 million in Q4 2025.